4/A
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0000899243-19-004317
Chairman sold 20,832 shares at $69.59 ($1,449,699)
- Chairman acquired 81,005 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
El-Hibri Fuad · Chairman
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-11-19 | Exercise or conversion : show line 1 in the form | +20,000 | $14.44 | $288,800 | 1,508,675 | D |
| 2018-11-20 | Exercise or conversion : show line 2 in the form | +15,173 | $14.44 | $219,098 | 1,503,848 | D |
| 2018-11-26 | Exercise or conversion : show line 3 in the form | +25,000 | $13.38 | $334,500 | 1,513,675 | D |
| 2018-11-27 | Exercise or conversion : show line 4 in the form | +20,832 | $13.38 | $278,732 | 1,509,507 | D |
| 2018-11-27 | Sale : show line 5 in the form | −20,832 | $69.59 | $1,449,699 | 1,488,675 | D |
| Open-market sales · 20,832 sh · avg $69.59 · $1,449,699 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-11-19 | Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) | −20,000 | 15,173 | D |
| 2018-11-20 | Exercise or conversion : show line 7 in the form Employee Stock Options (Right to Buy) | −15,173 | 0 | D |
| 2018-11-26 | Exercise or conversion : show line 8 in the form Employee Stock Options (Right to Buy) | −25,000 | 20,832 | D |
| 2018-11-27 | Exercise or conversion : show line 9 in the form Employee Stock Options (Right to Buy) | −20,832 | 0 | D |
Loading xslF345X03/doc4a.xml…